(Press-News.org) Contact information: Irene Sege
irene.sege@childrens.harvard.edu
617-919-7379
Dana-Farber Cancer Institute
High long-term survival of most common pediatric brain tumor, less when radiation was used
Largest-ever study of 20-year survival among pediatric low-grade glioma patients highlights radiation's association with higher mortality
BOSTON (Feb. 3, 2014) —The first comprehensive, large-scale cohort study of the long-term survival of children treated for low-grade gliomas, the most common pediatric brain tumor, finds that almost 90 percent are alive 20 years later and that few die from the tumor as adults. However, children who received radiation as part of their treatment had significantly lower long-term survival rates than children who were not radiated, researchers from Dana-Farber/Boston Children's Cancer and Blood Disorders Center report. These findings stand regardless of whether surgeons could successfully remove a child's entire tumor or only part of it, suggesting that the radiation itself may explain the difference.
The findings were published online by the journal Pediatric Blood and Cancer.
Delivery of radiation to children's developing brains has been linked to a number of adverse long-term effects, including cognitive development and endocrine function. While a number of major hospitals, including Dana-Farber/Boston Children's, have almost eliminated radiation in treating low-grade gliomas, the extent to which other institutions employ radiation varies, according to the study's senior author, Peter Manley, MD, of the Brain Tumor Center at Dana-Farber/Boston Children's.
"We found for the first time that once you survive your childhood with a low-grade glioma, you are not likely to die of that tumor as an adult," Manley said. "This is incredibly encouraging for patients and families. However, we also found some things that we are currently doing to treat low-grade gliomas, such as radiation, are increasing the rate of death later, so that as an adult you won't die of the tumor, but you may die from the treatment."
The data did not allow researchers to determine the precise mechanism driving the association between radiation treatment and reduced long-term survival (e.g., second cancers, other radiation-induced toxicities). However, given the excellent overall long-term survival findings among the patients studied, the team believes that doctors treating children for a pediatric low-grade glioma should make reducing long-term toxicity risk one of their primary concerns.
"We strongly recommend treatments that are less likely to cause long-term effects and second cancers," Manley said. "According to our analysis, radiation was the most common factor linked to differences in mortality among long-term survivors," he added. "There are multiple options available today for treating children with these tumors. We should exhaust all those before considering the use of radiation."
Low-grade gliomas—a family of non-malignant, usually non-aggressive tumors that includes pilocytic astrocytomas, diffuse astrocytomas and mixed gliomas— account for about 30 percent of all childhood brain tumors. Treatment typically consists of surgery and chemotherapy. Radiation, once a key component of therapy for these gliomas, has been falling out of favor since the mid-1990s, as it has for other childhood cancers such as Hodgkin's lymphoma and germ cell tumors.
To better understand survival factors among this population, Manley, lead author Pratiti Bandopadhayay, MBBS, PhD, of Dana-Farber/Boston Children's, and their collaborators analyzed Surveillance, Epidemiology and End Results (SEER) data from the National Cancer Institute on more than 4,000 patients diagnosed with pediatric low-grade gliomas between 1973 and 2008. Eighteen percent of the patients in the cohort received radiation as part of their treatment.
Overall the prognosis for children with low-grade gliomas is quite good, with five- and 10-year survival rates approaching 90 percent. Until now, though, the long-term survival—20 years and beyond—of adult survivors has never been comprehensively studied. Manley and his colleagues found little drop-off in survival at 20 years post-treatment, with almost 90 percent of pediatric survivors still alive.
Strikingly, though, only about 70 percent of patients treated with radiation were still alive 20 years after treatment. Other factors that affected survival included tumor location (cerebellum or not), tumor type (pilocytic or not), aggressiveness of the tumor (grade 1 vs. grade 2), year of diagnosis (before or after 1990) and age at diagnosis (
High long-term survival of most common pediatric brain tumor, less when radiation was used
Largest-ever study of 20-year survival among pediatric low-grade glioma patients highlights radiation's association with higher mortality
2014-02-04
ELSE PRESS RELEASES FROM THIS DATE:
NIH study describes new method for tracking T cells in HIV patients
2014-02-04
WHAT:
A team of researchers has reported a novel method for tracking CD4+ ...
EARTH Magazine: Warring trolls explanation for mysterious basalt pillars revised
2014-02-04
Alexandria, VA – A complex interaction between lava and water, rather than a fight between mythical troll-beasts of lore, is responsible for the occurrence of rare terrestrial ...
Finding a target for tumor suppression
2014-02-04
One of the hopes for victory against cancer hinges on naturally-occurring proteins whose job is to make their host cell die.
Since their natural role is to stop ...
Newly discovered signaling pathway could impact a variety of autoinflammatory diseases
2014-02-04
Researchers from Virginia Commonwealth University (VCU) Massey Cancer Center have discovered a new signaling pathway in sterile inflammation that could impact the ...
The art and science of cognitive rehabilitation therapy
2014-02-04
Amsterdam, NL, February 4, 2014 – There is a growing need for Cognitive Rehabilitation Therapy (CRT) due to the huge influx of soldiers ...
New technique could be used to search space dust for life's ingredients
2014-02-04
While the origin of life remains mysterious, scientists are finding more and more evidence that material created in space and delivered to Earth by comet and meteor ...
Blue light may fight fatigue around the clock
2014-02-04
Boston, MA-- Researchers from Brigham and Women's Hospital (BWH) have found that exposure to short wavelength, or ...
Cell division finding could boost understanding of cancer
2014-02-04
New insights into how the cells in our bodies divide could improve our knowledge of a condition linked to cancer, a study suggests.
Errors in the cell division process – which allows us to grow ...
Novel technique increases detection rate in screening mammography
2014-02-04
OAK BROOK, Ill. – Digital mammography screening with new photon-counting technique offers high diagnostic performance, according to a study published online in the journal Radiology.
As ...
Marker may predict response to ipilimumab in advanced melanoma
2014-02-04
PHILADELPHIA — Among patients with advanced melanoma, presence of higher levels of the protein vascular endothelial growth factor (VEGF) in blood was associated with poor response ...
LAST 30 PRESS RELEASES:
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project
[Press-News.org] High long-term survival of most common pediatric brain tumor, less when radiation was usedLargest-ever study of 20-year survival among pediatric low-grade glioma patients highlights radiation's association with higher mortality